A bill for an act establishing the medical spa oversight Act, and making penalties applicable.
House Study Bill 591 creates a new chapter in Iowa law called the Medical Spa Oversight Act and places medical spas under licensing and oversight by the state board of medicine. The bill defines a medical spa as a business licensed to provide certain “wellness services,” such as Botox injections, laser hair removal, skin pigmentation treatment, microneedling, intravenous nutrient therapy, and intramuscular nutrient injections. It also defines related terms covering prescription drugs, devices, adverse events, and the “responsible person” who must oversee compliance at each location.
The bill generally prohibits a business from operating as a medical spa, providing wellness services, or handling prescription drugs unless licensed. It requires public posting of licensed medical spas and key business information, sets storage, supervision, and security standards for prescription drugs and devices, and requires each location to designate a licensed responsible person. It also authorizes inspections and audits before initial licensure and periodically afterward, and requires reporting of serious adverse events to the board within five business days. In addition, the bill treats certain false or misleading claims about drugs or wellness services as unfair trade practices under Iowa consumer fraud law.
The bill would add a new regulatory framework to Iowa Code chapter 135S and amend Iowa’s consumer fraud statute, section 714.16, to make violations of the medical spa advertising provisions an unlawful practice. It gives the board of medicine enforcement authority, including injunction actions, administrative penalties of up to $500 per violation, and rulemaking power to implement the chapter. It also creates public-record and public-database requirements for licensed medical spas and disciplinary actions, while requiring compliance with federal drug supply chain and storage standards for dispensers.
No committee transcript or vote record is provided, so there is no direct evidence of support or opposition from lawmakers in the available materials. Based on the bill text, the measure appears to be framed as a consumer protection and patient-safety regulation aimed at bringing medical spas under clearer state oversight. The overall tone of the proposal is regulatory and compliance-focused rather than permissive or deregulatory.
The main points of potential contention are likely to be the scope of state regulation over medical spas, the licensing requirement for businesses providing aesthetic and wellness services, and the board of medicine’s authority to inspect, audit, and penalize facilities. Businesses may object to the costs and administrative burden of licensure, responsible-person requirements, public disclosure, and compliance with drug-handling rules. Another likely issue is the bill’s treatment of certain wellness services and advertising claims as regulated medical activity and consumer fraud, which could raise concerns about how broadly the state is defining and policing these services.